STAAR Surgical Company beat EPS estimates 81% of the time across 16 reported quarters (13 beats, 3 misses), averaging +27.9% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | not reported | $0.18 | not reported | not reported | |
| Q1 FY26 | not reported | $0.29 | not reported | not reported | |
| Q4 FY25 | not reported | $-0.13 | not reported | not reported | Q4 FY25 call · transcript |
| Q3 FY25 | not reported | $0.30 | not reported | not reported | |
| Q2 FY25 | not reported | $-0.23 | not reported | not reported | |
| Q1 FY25 | $-0.66 | $-0.64 | +3.0% | Beat | |
| Q4 FY24 | not reported | $-0.59 | not reported | not reported | |
| Q3 FY24 | not reported | $0.23 | not reported | not reported | |
| Q2 FY24 | $0.10 | $0.15 | +50.0% | Beat | |
| Q1 FY24 | $-0.09 | $-0.07 | +22.2% | Beat | |
| Q4 FY23 | not reported | $0.24 | not reported | not reported | |
| Q3 FY23 | $0.13 | $0.13 | +0.0% | Beat |
Back to STAA overview · STAA holders · STAA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.